UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 80

Sortiert nach

A specialized method of sputum collection and processing for therapeutic interventions in cystic fibrosis

Journal of cystic fibrosis, 2019-03, Vol.18 (2), p.203-211

2019

Volltextzugriff (PDF)

Repeatability of transient elastography in children

Pediatric research, 2020-10, Vol.88 (4), p.587-592

2020

Volltextzugriff (PDF)

Pulmonary alveolar proteinosis

QJM : An International Journal of Medicine, 2018-03, Vol.111 (3), p.185-186

2018

Volltextzugriff (PDF)

Isolated Unilateral Pulmonary Artery Agenesis complicated by Symptomatic Aspergilloma

Irish medical journal, 2017-12, Vol.110 (10), p.656

2017

Volltextzugriff (PDF)

Risk factors for totally implantable venous access device-associated complications in cystic fibrosis

Irish journal of medical science, 2018-05, Vol.187 (2), p.429-434

2018

Volltextzugriff (PDF)

WS3.6 The CF-ABLE score: a novel clinical prediction tool in cystic fibrosis

Journal of cystic fibrosis, 2012-06, Vol.11, p.S7-S7

2012

Volltextzugriff (PDF)

Life threatening sepsis while on high dose steroids requiring extra-corporeal membrane oxygenation

Irish medical journal, 2013-07, Vol.106 (7), p.213-214

2013

Volltextzugriff (PDF)

WS7.4 Inhaled aztreonam lysine (Cayston) therapy significantly improves lung function, weight, hospitalisations and excerbation rates prospectively – an Irish and UK real world experience

Journal of cystic fibrosis, 2014-06, Vol.13, p.S15-S15

2014

Volltextzugriff (PDF)

59 Ralstonia mannitolilytica – an emerging threat in cystic fibrosis and lung transplantation

Journal of cystic fibrosis, 2015-06, Vol.14, p.S72-S72

2015

Volltextzugriff (PDF)

290 Comparison of totally implantable venous access device complications in a cystic fibrosis cohort and a haemodialysis cohort

Journal of cystic fibrosis, 2012-06, Vol.11, p.S131-S131

2012

Volltextzugriff (PDF)

WS18.02 ETI triple therapy shows sustained, progressive normalisation of airway cytokine and antiprotease balance and systemic inflammation over one year of treatment

Journal of cystic fibrosis, 2023-06, Vol.22, p.S34-S34

2023

Volltextzugriff (PDF)

54 UK and Ireland review of ivacaftor in severe CF: Impact on hospitalisations and antibiotic use

Journal of cystic fibrosis, 2013-06, Vol.12, p.S62-S62

2013

Volltextzugriff (PDF)

WS7.6 UK and Ireland review of ivacaftor in severe CF: Impact on lung function and weight

Journal of cystic fibrosis, 2013-06, Vol.12, p.S15-S15

2013

Volltextzugriff (PDF)

WS23.3 Sputum Candida albicans is associated with radiological abnormalities in a cystic fibrosis cohort

Journal of cystic fibrosis, 2012-06, Vol.11, p.S51-S51

2012

Volltextzugriff (PDF)

559: Impact of elexacaftor/tezacaftor/ivacaftor on airway levels of ATP and IL-1b, markers of cystic fibrosis inflammation

Journal of cystic fibrosis, 2021-11, Vol.20, p.S264

2021

Volltextzugriff (PDF)

550: Effect of elexacaftor/tezacaftor/ivacaftor on LPS- and ATP-induced inflammasome activation in monocytes of patients with cystic fibrosis

Journal of cystic fibrosis, 2021-11, Vol.20, p.S260

2021

Volltextzugriff (PDF)

WS05.3 P2X7 receptor inhibition limits inflammatory response of monocytes to LPS and ATP through inflammasome regulation in cystic fibrosis

Journal of cystic fibrosis, 2021, Vol.20, p.S9

2021

Volltextzugriff (PDF)

P071 Real-world pregnancy data and outcomes in an era post-CFTR modulation therapies: an Irish centre's perspective

Journal of cystic fibrosis, 2021, Vol.20, p.S60

2021

Volltextzugriff (PDF)

WS17.7 Itraconazole up-regulates the vitamin D receptor and reduces T-helper 2 responses in individuals with cystic fibrosis colonized with Aspergillus fumigatus

Journal of cystic fibrosis, 2012-06, Vol.11, p.S39-S39

2012

Volltextzugriff (PDF)

A31 MECHANISMS IN CYSTIC FIBROSIS AND OTHER BRONCHIECTATIC DISEASES: Alpha-1 Antitrypsin Is Less Effective At Inhibiting Neutrophil Elastase Activity And Cxcr1 Cleavage In Cystic Fibrosis Versus Non-Cf Bronchiectasis Respiratory Secretions Due To The Actions Of Other Serine And Non-Serine Proteases

American journal of respiratory and critical care medicine, 2017-01, Vol.195

2017

Volltextzugriff (PDF)

Thrombolysis for indwelling catheter related thrombosis and superior vena cava obstruction in cystic fibrosis: a case series

Irish journal of medical science, 2010-09, Vol.179 (3), p.469-470

2010

Volltextzugriff (PDF)

156 Multicenter validation of the CF-ABLE score as a predictor of outcome and therapeutic response in cystic fibrosis

Journal of cystic fibrosis, 2022-10, Vol.21, p.S91-S92

2022

Volltextzugriff (PDF)

Cystic fibrosis, common variable immunodeficiency and Aspergers syndrome: an immunological and behavioural challenge

Irish journal of medical science, 2011-06, Vol.180 (2), p.607-609

2011

Volltextzugriff (PDF)

D92 REFINING THE EVALUATION AND TREATMENT OF CYSTIC FIBROSIS: Cystic Fibrosis Related Diabetes: An Audit

American journal of respiratory and critical care medicine, 2016-01, Vol.193, p.1

2016

Volltextzugriff (PDF)

WS03.05 Multicenter validation of the cystic fibrosis-ABLE score as a predictor of outcome and therapeutic response in cystic fibrosis

Journal of cystic fibrosis, 2023-06, Vol.22, p.S6-S7

2023

Volltextzugriff (PDF)

1 – 25 von 80

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(72)
Mit Volltextzugriff
(74)

Publikationsform

Sprache

Englisch
(79)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A specialized method of sputum collection and processing for therapeutic interventions in cystic fibrosis

Repeatability of transient elastography in children

Pulmonary alveolar proteinosis

Isolated Unilateral Pulmonary Artery Agenesis complicated by Symptomatic Aspergilloma

Risk factors for totally implantable venous access device-associated complications in cystic fibrosis

WS3.6 The CF-ABLE score: a novel clinical prediction tool in cystic fibrosis

Life threatening sepsis while on high dose steroids requiring extra-corporeal membrane oxygenation

WS7.4 Inhaled aztreonam lysine (Cayston) therapy significantly improves lung function, weight, hospitalisations and excerbation rates prospectively – an Irish and UK real world experience

59 Ralstonia mannitolilytica – an emerging threat in cystic fibrosis and lung transplantation

290 Comparison of totally implantable venous access device complications in a cystic fibrosis cohort and a haemodialysis cohort

WS18.02 ETI triple therapy shows sustained, progressive normalisation of airway cytokine and antiprotease balance and systemic inflammation over one year of treatment

54 UK and Ireland review of ivacaftor in severe CF: Impact on hospitalisations and antibiotic use

WS7.6 UK and Ireland review of ivacaftor in severe CF: Impact on lung function and weight

WS23.3 Sputum Candida albicans is associated with radiological abnormalities in a cystic fibrosis cohort

559: Impact of elexacaftor/tezacaftor/ivacaftor on airway levels of ATP and IL-1b, markers of cystic fibrosis inflammation

550: Effect of elexacaftor/tezacaftor/ivacaftor on LPS- and ATP-induced inflammasome activation in monocytes of patients with cystic fibrosis

WS05.3 P2X7 receptor inhibition limits inflammatory response of monocytes to LPS and ATP through inflammasome regulation in cystic fibrosis

P071 Real-world pregnancy data and outcomes in an era post-CFTR modulation therapies: an Irish centre's perspective

WS17.7 Itraconazole up-regulates the vitamin D receptor and reduces T-helper 2 responses in individuals with cystic fibrosis colonized with Aspergillus fumigatus

A31 MECHANISMS IN CYSTIC FIBROSIS AND OTHER BRONCHIECTATIC DISEASES: Alpha-1 Antitrypsin Is Less Effective At Inhibiting Neutrophil Elastase Activity And Cxcr1 Cleavage In Cystic Fibrosis Versus Non-Cf Bronchiectasis Respiratory Secretions Due To The Actions Of Other Serine And Non-Serine Proteases

Thrombolysis for indwelling catheter related thrombosis and superior vena cava obstruction in cystic fibrosis: a case series

156 Multicenter validation of the CF-ABLE score as a predictor of outcome and therapeutic response in cystic fibrosis

Cystic fibrosis, common variable immunodeficiency and Aspergers syndrome: an immunological and behavioural challenge

D92 REFINING THE EVALUATION AND TREATMENT OF CYSTIC FIBROSIS: Cystic Fibrosis Related Diabetes: An Audit

WS03.05 Multicenter validation of the cystic fibrosis-ABLE score as a predictor of outcome and therapeutic response in cystic fibrosis

Suchergebnisse filtern